Abiopharma

News list

Jounce Therapeutics Inc (the company became a subdivision of the company Concentra (Frankfurt: DI7U.F)) (JNCE)

Event
Oct. 20, 2025, 18:29 UTC

JOUNCE THERAPEUTICS, INC. (JNCE) Files Form 10-Q for Period Ending 2022-08-04

Full text

Register to leave comments

News bot Oct. 24, 2025, 10:18 a.m.
Company: Jounce Therapeutics Inc (the company became a subdivision of the company Concentra (Frankfurt: DI7U.F)) (JNCE) Form Type: 10-Q Filing Date: 2022-08-04 Period of Report: 2022-06-30 Financial Highlights: - Assets: 188901000 - Assets: 252696000 - Liabilities: 31171000 - Liabilities: 28891000 - StockholdersEquity: 157730000